Rice University logo Institute of Biosciences and Bioengineering Med into Grad, Department of Bioengineering MD Anderson Cancer Center Howard Hughes Medical Institute
 
Top blue bar image
  • Rice University welcomes the 2013-2014 HHMI MIG Fellows
 

Contact Us

Mailing Address
Institute of Biosciences and Bioengineering, MS-144
Rice University
P.O. Box 1892
Houston, Texas 77251-1892

Physical Address
Institute of Biosciences and Bioengineering, MS-144
Suite 170 BioScience Research Collaborative (BRC)
Rice University
Houston, Texas 77005-1827

Email: hhmimig@rice.edu  

Share

Welcome to Med Into Grad

Med Into Grad is a Ph.D. training program in Translational Cancer Diagnostics and Therapeutics Research for Bioengineers and Biophysicists that integrates cancer biology, clinical medicine, translational research, and bioengineering.

As partners, Rice University and The University of Texas MD Anderson Cancer Center have developed a unique training program for bioengineering graduate students that integrates:

  • Courses in cancer biology, clinical medicine, bioengineering and translational research,
  • Unique internship in clinical cancer care and translational research, and
  • Jointly mentored interdisciplinary Ph.D. projects.

    2014MIGLab  















    2014 Med Into Grad fellows embedding human tissue specimens in lab. 
    2014MIGLab2  
     

News and Media

Rice University Welcomes the 2014-2015 HHMI MIG Fellows

The newest HHMI MIG Fellows were welcomed to the BioScience Research Collaborative on June 10th, 2014.  Read more »   


   

Our Program

Download the Application & Program Flyer
2014 Rice University / UT MD Anderson Med Into Grad Program in Translational Cancer Diagnostics & Therapeutics Research for Bioengineers & Biophysicists


Videos

Lissett Bickford

Short videos of Med Into Grad Fellows, Lissett Bickford, Darren Roblyer  and Nadhi Thekke, discussing their experiences in the program: (Requires Windows Media Player.) »


Events


Tuesday, September 23, 2014
Translational Cancer Diagnostics and Therapeutics Seminar

12 Noon - 1 PM, BRC 172
HHMI MIG Seminar
Dr. Atul Varadhachary (Managing Partner - Fannin Innovation Studio)